IRCT20211019052811N1招募中3 期
Evaluation of the effect of cannabidiol in the treatment of adult dystonias-a randomized placebo-controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with focal-generalized dystonia
- •Failure to improve the patient's dystonic symptoms with previous drug treatments
排除标准
- •Evidence that dystonia is secondary to other diseases
- •History of liver disease
- •Pregnancy or intent to conceive or breastfeed
- •History of dystonic surgery, including deep brain stimulation and destructive surgery
研究者
相似试验
招募中
不适用
Cannabidiol enhancement of exposure therapy in patients with phobias.Phobic anxiety disorders, fobische angststoornissenNL-OMON28305trecht University72
进行中（未招募）
不适用
Does adding cannabidiol (a component of cannabis) enhance the treatment of phobias where patients are confronted with their fears (exposure treatment).EUCTR2014-004094-17-NLniversiteit Utrecht
已完成
3 期
Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias.Phobic anxiety disorders10002861NL-OMON44760niversiteit Utrecht72
尚未招募
3 期
Canabidiol (CBD) for Treatment of Frontal Lobe EpilepsyTreatment Resistant Epilepsy.Epilepsy and recurrent seizuresIRCT20210608051515N1Tehran University of Medical Sciences30
尚未招募
1 期
Evaluation of the use of Cannabidiol in Third Molar ExtractioRBR-8rv93wnniversidade Federal de Uberlândia